These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 36909599)

  • 1. FOXP3
    Martinez HA; Koliesnik I; Kaber G; Reid JK; Nagy N; Barlow G; Falk BA; Medina CO; Hargil A; Vlodavsky I; Li JP; Pérez-Cruz M; Tang SW; Meyer EH; Wrenshall LE; Lord JD; Garcia KC; Palmer TD; Steinman L; Nepom GT; Wight TN; Bollyky PL; Kuipers HF
    bioRxiv; 2023 Feb; ():. PubMed ID: 36909599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulatory T cells use heparanase to access IL-2 bound to extracellular matrix in inflamed tissue.
    Martinez HA; Koliesnik I; Kaber G; Reid JK; Nagy N; Barlow G; Falk BA; Medina CO; Hargil A; Zihsler S; Vlodavsky I; Li JP; Pérez-Cruz M; Tang SW; Meyer EH; Wrenshall LE; Lord JD; Garcia KC; Palmer TD; Steinman L; Nepom GT; Wight TN; Bollyky PL; Kuipers HF
    Nat Commun; 2024 Feb; 15(1):1564. PubMed ID: 38378682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of the heparan sulfate-degrading enzyme heparanase is induced in infiltrating CD4
    de Mestre AM; Staykova MA; Hornby JR; Willenborg DO; Hulett MD
    J Leukoc Biol; 2007 Nov; 82(5):1289-1300. PubMed ID: 29350861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparanase degrades syndecan-1 and perlecan heparan sulfate: functional implications for tumor cell invasion.
    Reiland J; Sanderson RD; Waguespack M; Barker SA; Long R; Carson DD; Marchetti D
    J Biol Chem; 2004 Feb; 279(9):8047-55. PubMed ID: 14630925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of the heparan sulfate-degrading enzyme heparanase is induced in infiltrating CD4+ T cells in experimental autoimmune encephalomyelitis and regulated at the level of transcription by early growth response gene 1.
    de Mestre AM; Staykova MA; Hornby JR; Willenborg DO; Hulett MD
    J Leukoc Biol; 2007 Nov; 82(5):1289-300. PubMed ID: 17656651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-Zone IL-2 Signaling: Fusion Proteins Containing Linked CD25 and IL-2 Domains Sustain Tolerogenic Vaccination
    DeOca KB; Moorman CD; Garcia BL; Mannie MD
    Front Immunol; 2020; 11():541619. PubMed ID: 33072087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparanase and autoimmune diabetes.
    Simeonovic CJ; Ziolkowski AF; Wu Z; Choong FJ; Freeman C; Parish CR
    Front Immunol; 2013 Dec; 4():471. PubMed ID: 24421779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treg-specific IL-27Rα deletion uncovers a key role for IL-27 in Treg function to control autoimmunity.
    Do J; Kim D; Kim S; Valentin-Torres A; Dvorina N; Jang E; Nagarajavel V; DeSilva TM; Li X; Ting AH; Vignali DAA; Stohlman SA; Baldwin WM; Min B
    Proc Natl Acad Sci U S A; 2017 Sep; 114(38):10190-10195. PubMed ID: 28874534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemical toolbox to interrogate Heparanase-1 activity.
    Rabinowitz ZM; Somers J; Wang Z; Cui L
    Curr Opin Chem Biol; 2024 Jun; 80():102452. PubMed ID: 38555836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of heparanase via IL-10 correlates with a high infiltration of CD163+ M2-type tumor-associated macrophages in inflammatory breast carcinomas.
    El-Nadi M; Hassan H; Saleh ME; Nassar E; Ismail YM; Amer M; Greve B; Götte M; El-Shinawi M; Ibrahim SA
    Matrix Biol Plus; 2020 May; 6-7():100030. PubMed ID: 33543027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-reducing end labeling of heparan sulfate via click chemistry and a high throughput ELISA assay for heparanase.
    Wu ZL; Huang X; Ethen CM; Tatge T; Pasek M; Zaia J
    Glycobiology; 2017 Jun; 27(6):518-524. PubMed ID: 28025251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A GMCSF-Neuroantigen Tolerogenic Vaccine Elicits Systemic Lymphocytosis of CD4
    Moorman CD; Curtis AD; Bastian AG; Elliott SE; Mannie MD
    Front Immunol; 2018; 9():3119. PubMed ID: 30687323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombin enhances degradation of heparan sulfate in the extracellular matrix by tumor cell heparanase.
    Benezra M; Vlodavsky I; Bar-Shavit R
    Exp Cell Res; 1992 Jul; 201(1):208-15. PubMed ID: 1612123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Fluorogenic Green Merocyanine-Based Probe to Detect Heparanase-1 Activity.
    Rabinowitz ZM; Wang Z; Liu J; Zhang Y; Ybargollin AJ; Saketkhou M; Cui L
    bioRxiv; 2024 Feb; ():. PubMed ID: 38464176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unexpected new roles for heparanase in Type 1 diabetes and immune gene regulation.
    Parish CR; Freeman C; Ziolkowski AF; He YQ; Sutcliffe EL; Zafar A; Rao S; Simeonovic CJ
    Matrix Biol; 2013 Jun; 32(5):228-33. PubMed ID: 23499527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparanase: A Multitasking Protein Involved in Extracellular Matrix (ECM) Remodeling and Intracellular Events.
    Masola V; Bellin G; Gambaro G; Onisto M
    Cells; 2018 Nov; 7(12):. PubMed ID: 30487472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primaquine elicits Foxp3
    Thome R; Casella G; Lotfi N; Ishikawa LWL; Wang Q; Ciric B; Zhang GX; Rostami A
    J Autoimmun; 2020 Nov; 114():102505. PubMed ID: 32595012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism-based heparanase inhibitors reduce cancer metastasis in vivo.
    de Boer C; Armstrong Z; Lit VAJ; Barash U; Ruijgrok G; Boyango I; Weitzenberg MM; Schröder SP; Sarris AJC; Meeuwenoord NJ; Bule P; Kayal Y; Ilan N; Codée JDC; Vlodavsky I; Overkleeft HS; Davies GJ; Wu L
    Proc Natl Acad Sci U S A; 2022 Aug; 119(31):e2203167119. PubMed ID: 35881786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How GRAIL controls Treg function to maintain self-tolerance.
    Fathman CG; Yip L; Gómez-Martín D; Yu M; Seroogy CM; Hurt CR; Lin JT; Jenks JA; Nadeau KC; Soares L
    Front Immunol; 2022; 13():1046631. PubMed ID: 36569931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A GM-CSF-neuroantigen tolerogenic vaccine elicits inefficient antigen recognition events below the CD40L triggering threshold to expand CD4
    Moorman CD; Bastian AG; DeOca KB; Mannie MD
    J Neuroinflammation; 2020 Jun; 17(1):180. PubMed ID: 32522287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.